Plotkin's Vaccines,E-Book (eBook)
1734 Seiten
Elsevier Health Sciences (Verlag)
978-0-323-79059-8 (ISBN)
-
Contains all-new chapters on COVID-19, vaccine hesitancy, and non-specific effects of vaccines, as well as significantly revised content on new vaccine technologies such as mRNA vaccines, emerging vaccines, and technologies to improve immunization.
-
Presents exciting new data on evolution of adjuvants across the centuries, dengue vaccines, human papillomavirus vaccines, respiratory syncytial virus vaccines, tuberculosis vaccines, and zoster vaccines.
-
Provides up-to-date, authoritative information on vaccine production, available preparations, efficacy and safety, and recommendations for vaccine use, with rationales and data on the impact of vaccination programs on morbidity and mortality.
-
Provides complete coverage of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
-
Keeps you up to date with information on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
-
Covers vaccine-preventable diseases, vaccine science, and licensed vaccine products, as well as product technologies and global regulatory and public health issues.
-
Analyzes the cost-benefit and cost-effectiveness of different vaccine options.
-
Helps you clearly visualize concepts and objective data through an abundance of tables and figures.
From the latest vaccination evidence, recommendations, and protocols . . . to new vaccine development and the use of vaccines in reducing disease, Plotkin's Vaccines, 8th Edition, covers every aspect of vaccination. Now completely revised and updated from cover to cover, this award-winning text continues to provide reliable information from global authorities, offering a complete understanding of each disease, as well as the latest knowledge of both existing vaccines and those currently in research and development. Described by Bill Gates as "e;an indispensable guide to the enhancement of the well-being of our world,"e; Plotkin's Vaccines is a must-have reference for current, authoritative information in this fast-moving field. - Contains all-new chapters on COVID-19, vaccine hesitancy, and non-specific effects of vaccines, as well as significantly revised content on new vaccine technologies such as mRNA vaccines, emerging vaccines, and technologies to improve immunization. - Presents exciting new data on evolution of adjuvants across the centuries, dengue vaccines, human papillomavirus vaccines, respiratory syncytial virus vaccines, tuberculosis vaccines, and zoster vaccines. - Provides up-to-date, authoritative information on vaccine production, available preparations, efficacy and safety, and recommendations for vaccine use, with rationales and data on the impact of vaccination programs on morbidity and mortality. - Provides complete coverage of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues. - Keeps you up to date with information on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies. - Covers vaccine-preventable diseases, vaccine science, and licensed vaccine products, as well as product technologies and global regulatory and public health issues. - Analyzes the cost-benefit and cost-effectiveness of different vaccine options. - Helps you clearly visualize concepts and objective data through an abundance of tables and figures. - Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.
Contributors
Mark J. Abzug, MD
Professor of Pediatrics (Infectious Diseases)
Department of Pediatrics
University of Colorado School of Medicine;
Children's Hospital Colorado
Aurora, Colorado
Priyamvada Acharya, PhD
Associate Professor of Surgery
Duke University Medical Center;
Director, Division of Structural Biology
Duke Human Vaccine Institute, Duke University
Durham, North Carolina
Anna M. Acosta, MD
Medical Epidemiologist
Division of Bacterial Diseases
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Atlanta, Georgia
S. Sohail Ahmed, MD, MBA
Chief Medical Officer
Kling Biotherapeutics
Amsterdam, Netherlands
Ian J. Amanna, PhD
Vice President for Research and Development
Najít Technologies, Inc.
Beaverton, Oregon
Annaliesa S. Anderson, PhD
Senior Vice President and Head
Vaccine Research and Development
Pfizer, Inc.
Pearl River, New York
Edwin J. Asturias, MD
Professor of Pediatrics
University of Colorado School of Medicine;
Professor of Epidemiology
Colorado School of Public Health;
Associate Director
Center for Global Health
Colorado School of Public Health
Aurora, Colorado
Martin F. Bachmann, PhD
Professor
Department of BioMedical Research, Immunology RIA, Inselspital
University of Bern
Bern, Switzerland;
Professor
The Jenner Institute
Nuffield Department of Medicine
University of Oxford
Oxford, United Kingdom
Sunil Bahl, MBBS, MD
Coordinator
Immunization and Vaccine Development
Department of Communicable Diseases
World Health Organization, South-East Asia Regional Office
New Delhi, India
Justin R. Bailey, MD, PhD
Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland
Carol J. Baker, MD
Professor, Pediatrics/Infectious Diseases
McGovern Medical School
University of Texas Health Science Center
Houston, Texas
Henry H. Balfour Jr, MD
Professor, Laboratory Medicine and Pathology,
Professor, Pediatrics
University of Minnesota Medical School
Minneapolis, Minnesota
Ralph S. Baric, PhD
Epidemiologist
University of North Carolina
Chapel Hill, North Carolina
Elizabeth D. Barnett, MD
Professor of Pediatrics
Department of Pediatrics
Boston University School of Medicine
Boston, Massachusetts
Alan D.T. Barrett, PhD, DSc (Hon)
Director
Sealy Institute for Vaccine Sciences;
Professor
Department of Pathology
University of Texas Medical Branch
Galveston, Texas
Jessica A. Belser, PhD
Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Atlanta, Georgia
Jay A. Berzofsky, MD, PhD
Branch Chief
Vaccine Branch
Center for Cancer Research
National Cancer Institute
Bethesda, Maryland
Jeffrey M. Bethony, MS, PhD
Professor
Microbiology, Immunology, and Tropical Medicine
The George Washington University
Washington, District of Columbia
Paul D. Brewer-Jensen
Research specialist, Biotech
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Andrew N. Bubak, MS, PhD
Assistant Professor
Department of Neurology
University of Colorado School of Medicine
Aurora, Colorado
Cara C. Burns, PhD
Lead Microbiologist
Division of Viral Diseases
Centers for Disease Control and Prevention
Atlanta, Georgia
Arthur L. Caplan, PhD
Drs. William F. and Virginia Connolly Mitty Professor of Bioethics
Department of Population Health
NYU Grossman School of Medicine
New York, New York
Marco Cavaleri, PhD
European Medicines Agency
Amsterdam, Netherland
Aruna Chandran, MD, MPH
Senior Scientist, Epidemiology
Johns Hopkins Bloomberg School of Public Health
Baltimore, Maryland
Thomas Cherian, MBBS, DCH, MD (Paed)
Managing Partner
MMGH Consulting
Geneva, Switzerland
John D. Clemens, MD
Executive Director, Director's Office
International Centre for Diarrheal Disease Research
Dhaka, Bangladesh
Emil Cochino, MD
European Medicines Agency
Amsterdam, Netherland
Catherine Cohet, PhD
European Medicines Agency
Amsterdam, Netherland
Amanda Cohn, MD
Chief Medical Officer
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Atlanta, Georgia
Margaret M. Cortese, MD
Division of Viral Diseases
Centers for Disease Control and Prevention
Atlanta, Georgia
Natasha S. Crowcroft, MBBS, MSc, MD (Cantab)
Senior Technical Advisor of Measles and Rubella
Department of Immunization, Vaccines and Biologicals
World Health Organization
Geneva, Switzerland
Nigel Curtis, DCH, DTM&H, MRCP, MRCPCH, PhD
Professor of Paediatric Infectious Diseases
Department of Paediatrics
The University of Melbourne;
Head of Infectious Diseases
The Royal Children's Hospital Melbourne;
Group Leader, Infectious Diseases Group
Murdoch Children's Research Institute
Parkville, Victoria, Australia
F. Heath Damron, PhD
Associate Professor
Department of Microbiology, Immunology and Cell Biology
Director of the Vaccine Development center
West Virginia University-Health Sciences Center
Morgantown, West Virginia
Margie Danchin, MBBS, PhD, FRACP
Associate Professor
Vaccine Uptake Group
Murdoch Children's Research Institute;
Department of Paediatrics
University of Melbourne;
Department of General Medicine
Royal Children's Hospital
Melbourne, Australia
Kari Debbink, PhD
Associate Scientist
Department of Molecular Microbiology and Immunology
Johns Hopkins Bloomberg School of Public Health
Baltimore, Maryland
Sachin N. Desai, MD
Adjunct Assistant Professor
Department of Pediatrics
Center for Vaccine Development and Global Health
University of Maryland School of Medicine
Baltimore, Maryland
Emily H. Davis, PhD
APHL Infectious Disease Fellow
Arboviral Diseases Branch
Centers for Disease Control and Prevention
Fort Collins, Colorado
Michael D. Decker, MD, MPH
Adjunct Professor of Preventive Medicine
Department of Health Policy
Vanderbilt University Medical Center
Nashville, Tennessee
Mark R. Denison, MD
Professor
Department of Pediatrics
Vanderbilt University Medical Center
Nashville, Tennessee
Frank DeStefano, MD, MPH
Director
Immunization Safety Office
Centers for Disease Control and Prevention
Atlanta, Georgia
R. Gordon Douglas, AB, MD
Professor Emeritus Medicine
Weill Cornell Medical College
New York, New York
Sheila M. Dreher-Lesnick, PhD
Consumer Safety Officer
Division of Bacterial Parasitic and Allergenic Products
Office of Vaccines Research and Review
Center for Biologics Evaluation and Research (CBER)
Food and Drug Administration
Silver Spring, Maryland
Christiane S. Eberhardt, MD
Center for Vaccinology
Medical Faculty and University Hospitals of Geneva
Geneva, Switzerland
W. John Edmunds
Professor of Infectious Disease Modelling
London School of Hygiene and Tropical Medicine
London, United Kingdom
Caitlin E. Edwards, MS, MPH
Research Specialist
Department of Epidemiology
University of North Carolina-Chapel Hill
Chapel Hill, North Carolina
Kathryn M. Edwards, MD
Sarah H. Sell and Cornelius Vanderbilt Chair in Pediatrics
Professor of Pediatrics
Division of Pediatric Infectious Diseases
Former Director, Vanderbilt Vaccine Research Program
Vanderbilt University
Nashville, Tennessee
Rudolf Eggers, MBChB, MMed
Director, Integrated Health Services
World Health Organization
Geneva, Switzerland
Ronald Ellis, PhD, MBA
Principal Consultant
Human Vaccines and Immunotherapeutics
Jerusalem, Israel
Dean D. Erdman, Dr.P.H
Retired
Division of Viral Diseases
National Center for...
Erscheint lt. Verlag | 31.3.2023 |
---|---|
Sprache | englisch |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Innere Medizin |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Pädiatrie | |
Studium ► Querschnittsbereiche ► Infektiologie / Immunologie | |
ISBN-10 | 0-323-79059-3 / 0323790593 |
ISBN-13 | 978-0-323-79059-8 / 9780323790598 |
Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
Haben Sie eine Frage zum Produkt? |
Größe: 62,1 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belletristik und Sachbüchern. Der Fließtext wird dynamisch an die Display- und Schriftgröße angepasst. Auch für mobile Lesegeräte ist EPUB daher gut geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich